Analysts: Sarepta Therapeutics Inc (AB3A.F)

AB3A.F on Frankfurt Stock Exchange

16.56EUR
21 Aug 2014
Price Change (% chg)

€-0.09 (-0.54%)
Prev Close
€16.65
Open
€16.25
Day's High
€16.56
Day's Low
€16.25
Volume
130
Avg. Vol
381
52-wk High
€40.75
52-wk Low
€9.35

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.95 December 22 Aug 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 3 3 4
(2) OUTPERFORM 4 4 5 4
(3) HOLD 6 5 5 5
(4) UNDERPERFORM 1 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.44 2.38 2.36 2.29

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 13 3.07 7.00 0.10 3.59
Quarter Ending Dec-14 13 2.83 7.00 0.10 33.14
Year Ending Dec-14 14 14.66 22.67 8.88 35.45
Year Ending Dec-15 12 50.10 247.70 1.70 116.81
Earnings (per share)
Quarter Ending Sep-14 13 -0.95 -0.69 -1.24 -0.87
Quarter Ending Dec-14 13 -1.07 -0.73 -1.45 -0.23
Year Ending Dec-14 14 -3.56 -2.96 -4.12 -2.86
Year Ending Dec-15 14 -3.42 -1.55 -4.24 -1.65
LT Growth Rate (%) 1 9.31 9.31 9.31 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 4.30 2.58 1.72 39.98
Quarter Ending Mar-14 3.54 6.09 2.55 72.09
Quarter Ending Dec-13 4.53 2.63 1.90 42.03
Quarter Ending Sep-13 4.57 4.17 0.41 8.88
Quarter Ending Jun-13 5.08 2.95 2.12 41.86
Earnings (per share)
Quarter Ending Jun-14 -0.76 -0.85 0.09 -12.24
Quarter Ending Mar-14 -0.80 -0.75 0.05 -5.91
Quarter Ending Dec-13 -0.69 -0.23 0.46 -66.87
Quarter Ending Sep-13 -0.65 -1.24 0.59 -91.51
Quarter Ending Jun-13 -0.61 -0.60 0.01 -1.49

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 3.07 3.07 4.58 4.58 3.59
Quarter Ending Dec-14 2.83 3.04 4.50 4.50 33.14
Year Ending Dec-14 14.66 14.86 19.34 19.34 35.45
Year Ending Dec-15 50.10 50.30 51.07 51.07 116.81
Earnings (per share)
Quarter Ending Sep-14 -0.95 -0.92 -0.77 -0.77 -0.87
Quarter Ending Dec-14 -1.07 -1.03 -0.83 -0.83 -0.23
Year Ending Dec-14 -3.56 -3.51 -3.07 -3.07 -2.86
Year Ending Dec-15 -3.42 -3.35 -2.85 -2.85 -1.65

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 7
Quarter Ending Dec-14 0 1 0 6
Year Ending Dec-14 0 1 1 10
Year Ending Dec-15 0 1 2 5
Earnings
Quarter Ending Sep-14 0 1 2 10
Quarter Ending Dec-14 0 1 1 11
Year Ending Dec-14 0 1 1 11
Year Ending Dec-15 0 1 1 10

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks